The	the	O	O	O	O
haemodynamic	haemodynamic	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
combination	combination	O	O	O	O
with	with	O	O	O	O
ephedrine	ephedrine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
elderly	elderly	O	O	O	O
patients	patients	O	O	O	O
(	(	O	O	O	O
ASA	asa	CHEMICALS	O	OTHERS	I
groups	groups	O	O	O	O
3	3	O	O	O	O
and	and	O	O	O	O
4).The	4).the	O	O	O	O
marked	marked	O	O	O	O
vasodilator	vasodilator	O	O	O	O
and	and	O	O	O	O
negative	negative	O	O	O	O
inotropic	inotropic	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
are	are	O	O	O	O
disadvantages	disadvantages	O	O	O	O
in	in	O	O	O	O
frail	frail	O	O	O	O
elderly	elderly	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
investigated	investigated	O	O	O	O
the	the	O	O	O	O
safety	safety	O	O	O	O
and	and	O	O	O	O
efficacy	efficacy	O	O	O	O
of	of	O	O	O	O
adding	adding	O	O	O	O
different	different	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
ephedrine	ephedrine	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
order	order	O	O	O	O
to	to	O	O	O	O
obtund	obtund	O	O	O	O
the	the	O	O	O	O
hypotensive	hypotensive	O	DISEASE	OTHERS	I
response	response	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
haemodynamic	haemodynamic	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
adding	adding	O	O	O	O
15	15	O	O	O	O
,	,	O	O	O	O
20	20	O	O	O	O
or	or	O	O	O	O
25	25	O	O	O	O
mg	mg	O	O	OTHERS	I
of	of	O	O	O	O
ephedrine	ephedrine	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
200	200	O	O	O	O
mg	mg	O	O	OTHERS	I
of	of	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
compared	compared	O	O	O	O
to	to	O	O	O	O
control	control	O	O	O	O
in	in	O	O	O	O
40	40	O	O	O	O
ASA	asa	CHEMICALS	O	OTHERS	I
3/4	3/4	O	O	O	O
patients	patients	O	O	O	O
over	over	O	O	O	O
60	60	O	O	O	O
years	years	O	O	O	O
presenting	presenting	O	O	O	O
for	for	O	O	O	O
genito-urinary	genito-urinary	O	O	O	O
surgery	surgery	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
addition	addition	O	O	O	O
of	of	O	O	O	O
ephedrine	ephedrine	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
appears	appears	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
an	an	O	O	O	O
effective	effective	O	O	O	O
method	method	O	O	O	O
of	of	O	O	O	O
obtunding	obtunding	O	O	O	O
the	the	O	O	O	O
hypotensive	hypotensive	O	DISEASE	OTHERS	I
response	response	O	O	O	O
to	to	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
at	at	O	O	O	O
all	all	O	O	O	O
doses	doses	O	O	O	O
used	used	O	O	O	O
in	in	O	O	O	O
this	this	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
marked	marked	O	O	O	O
tachycardia	tachycardia	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
ephedrine	ephedrine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
combination	combination	O	O	O	O
with	with	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
occurred	occurred	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
majority	majority	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
occasionally	occasionally	O	O	O	O
reaching	reaching	O	O	O	O
high	high	O	O	O	O
levels	levels	O	O	O	O
in	in	O	O	O	O
individual	individual	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

Due	due	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
tachycardia	tachycardia	O	DISEASE	OTHERS	I
inducing	inducing	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
ischemia	ischemia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
we	we	O	O	O	O
would	would	O	O	O	O
not	not	O	O	O	O
recommend	recommend	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
in	in	O	O	O	O
elderly	elderly	O	O	O	O
patients	patients	O	O	O	O
of	of	O	O	O	O
any	any	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
ephedrine/propofol/mixtures	ephedrine/propofol/mixtures	O	O	O	O
studied	studied	O	O	O	O
.	.	O	O	O	O

